From the 25th till the 29th of September, Vienna was host for the 18th ECCO – 40th ESMO European Cancer Congress. Immunotherapy was a very important theme for this year’s venue which hosted 18.500 registered attendees. This report will highlight 4 key studies concerning renal cell carcinoma and metastatic prostate cancer presented during the presidential sessions of the meeting.
(BELG J MED ONCOL 2015;9:244–49)
* (only possible for healthcare professionals with RIZIV/INAMI/MATRICULE working in the field of Oncology/Hemato-oncology in Belgium and Luxembourg with prescription authorisation)
** (for healthcare professionals with prescribing authorisation working outside the field of Oncology/Hemato-oncology in Belgium and Luxembourg as well as those without prescribing authorisation working as healthcare professional in Oncology/Hemato-oncology in Belgium and Luxembourg, plus persons without prescription authorisation working outside Belgium and Luxembourg, plus healthcare professionals with prescribing authorisation outside Belgium and Luxembourg plus non-healthcare professionals from outside or inside Belgium or Luxembourg)
Top
